N/A
N=25
A Pharmacist Intervention to Improve Mother and Child Health
Hypertension
Bottom Line
View on ClinicalTrials.gov: NCT06073054 ↗Enrolled (actual)
25
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Number of Participants Who Talk to Research Pharmacist — 20 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Research Pharmacist (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Iowa
- Primary completion
- Jul 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Talk to Research Pharmacist |
20 | — |
| PRIMARY Number of Participants Who Return BP Measurements |
22 | — |
| PRIMARY Percentage of Well-Child Visits Attended |
57 | — |
| PRIMARY Percentage of Vaccinations Received |
251 | — |
| SECONDARY Number of BP Measurements Submitted |
12.9 | — |
| SECONDARY Blood Pressure Control |
12 | — |
| SECONDARY Number of Participants Satisfied With the Study |
7 | — |
Summary
The goal of this clinical trial is to learn if a research pharmacist can improve the health of new mothers and their babies. The main questions it aims to answer are:
* Will postpartum women who had elevated blood pressure during pregnancy be willing to participate in the study, talk to a pharmacist about their health and the health of their child, and text us their blood pressure measurements?
* Will contact with the pharmacist improve the health of the mother and/or the child?
Participants will:
* complete a baseline demographic survey,
* be given a blood pressure cuff and taught how to use it,
* be asked to text us their blood pressure values 2 times per day for 7 days after enrollment,
* complete a phone call with a pharmacist discussing their health and the health of their baby,
* text us their blood pressure 1 time per day for 3 days 1 month after enrollment,
* have a 1 month follow-up phone call with the research pharmacist, and
* complete an exit survey to provide feedback about the study.
Eligibility Criteria
Inclusion Criteria
- biological mother of a baby attending a 1-week to 6-month well-child visit,
- received prenatal care at University of Iowa Hospitals and Clinics,
- had at least 2 elevated blood pressures (>= 130 mmHg systolic or >= 80 mmHg diastolic) during pregnancy,
- owns a smartphone
Exclusion Criteria
- arm circumference > 17 inches,
- prisoner status
- unable to provide own written informed consent
Data sourced from ClinicalTrials.gov (NCT06073054). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.